Longevity & AgingStem Cell and Senolytic Combo Extends Mouse Lifespan by Over 70%
Researchers from Immorta Bio and TAM Global tested a two-pronged treatment in mice combining SenoVax, a therapy that targets and removes aging, dysfunctional cells, with StemCellRevivify, a personalized stem cell treatment designed to restore tissue function. The result was a more than 70 percent increase in lifespan, along with sustained improvements in physical performance. The study involved scientists from leading institutions including the Buck Institute for Research on Aging, Stanford, Cedars-Sinai, and the University of Miami. While the findings are preclinical and require further validation before any human application, the scale of the effect is notable. The companies plan mechanistic follow-up studies and eventual clinical translation, and a full manuscript has been made available.
